Edition:
United Kingdom

Tocagen Inc (TOCA.OQ)

TOCA.OQ on NASDAQ Stock Exchange Global Select Market

11.87USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$11.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,231
52-wk High
$15.80
52-wk Low
$7.52

Chart for

About

Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to... (more)

Overall

Beta: --
Market Cap(Mil.): $206.81
Shares Outstanding(Mil.): 19.81
Dividend: --
Yield (%): --

Financials

  TOCA.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -1.99 -- --
ROI: -- -0.29 14.22
ROE: -- 0.40 15.99

BRIEF-Tocagen Entered Amended And Restated Loan And Security Agreement For $26.5 Mln

* TOCAGEN - ENTERED AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT FOR $26.5 MILLION AS TERM LOANS FUNDED ON EFFECTIVE DATE - SEC FILING Source text: (https://bit.ly/2IEQjX8) Further company coverage:

23 May 2018

Earnings vs. Estimates